Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
In a phase II study of the long-acting GLP-1RA efpeglenatide (4 mg once weekly, 6 mg once weekly, 6 mg once every 2 weeks, and 8 mg once every 2 weeks), patients with obesity and without diabetes had statistically significant reductions in body weight compared with placebo after 20 weeks of treatment (differences in least squares means were 6.3 to 7.2 kg
3 Because the Noom GLP-1 Rx Program includes medication, this equates to more than twice the amount of time on their included GLP-1
GHK-Cu injectable was included in that restricted category
Ma L, Chen C, Zhao C, Li T, Ma L, Jiang J, et al
At least 23 liters per day to support detoxification and absorption.
Patients should avoid injecting into areas with scarring, bruising, inflammation, or skin conditions
